•
AZ
AZN
AstraZeneca PLC
polygon--
Price Chart
Market Cap
280.73B
Volume
1.17M
52W High
$96.51
52W Low
$61.24
Open
$90.45
Prev Close
$90.54
Day Range
90.17 - 90.75
About AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
Latest News
Is This Dividend King Stock a Buy After a Major Development?
The Motley Fool•12h ago
High Potency APIs Market Size to Reach USD 58.68 Billion by 2033, Driven by the Increasing Demand for Targeted and Oncology Therapies – SNS Insider
GlobeNewswire Inc.•23h ago
AstraZeneca To Delist ADRs From Nasdaq By January, Eyes Broader Investor Reach
Benzinga•Yesterday
Bioconjugation Market Size to Hit USD 14.51 Billion by 2033, Driven by the Increasing Demand for Targeted Therapeutics – SNS Insider
GlobeNewswire Inc.•Jan 19
AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca
Benzinga•Jan 19
The Newest Stock in the Nasdaq-100 Soared 549,000% Since Its IPO, and It's Still a Buy Right Now, According to Wall Street (Hint: Not Strictly a Tech Company)
The Motley Fool•Jan 15
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.•Jan 15
Generalized Myasthenia Gravis Market Outlook Shows Strong Momentum During the Forecast Period (2025–2034) Driven by Novel Immunotherapies | DelveInsight
GlobeNewswire Inc.•Jan 14